Sam Brusco, Associate Editor08.04.23
Henry Schein has begun a deal to acquire majority ownership in Shield Healthcare, a supplier of homecare medical products delivered to patients in their homes. Adding Shield Healthcare aims to advance Henry Schein’s continuum-of-care delivery model.
This agreement follows Henry Schein’s 2021 grab of Prism Medical Products, and represents further investment in the homecare medical supplies market. The company stated this acquisition will bring its homecare medical products platform to a revenue base of over $300 million, annually.
The Shield Healthcare transaction enhances Henry Schein’s medical business with incontinence, urology, ostomy, enteral nutrition, advanced wound, and diabetes supplies, as well as continuous glucose monitoring devices. Headquartered in Valencia, Calif., Shield Healthcare had 2022 net sales of about $180 million.
“As the U.S. population ages and care increasingly moves into the home, Henry Schein is meeting this trend by enhancing our homecare medical products offering,” Stanley M. Bergman, chairman and CEO of Henry Schein told the press. “We are delighted to expand our presence in delivering medical products directly to patients through Shield Healthcare. Together, we share an unwavering commitment to customer satisfaction.”
In July, the company began a deal to acquire the S.I.N. implant system. A week later, it acquired Regional Health Care Group (RHCG).
This agreement follows Henry Schein’s 2021 grab of Prism Medical Products, and represents further investment in the homecare medical supplies market. The company stated this acquisition will bring its homecare medical products platform to a revenue base of over $300 million, annually.
The Shield Healthcare transaction enhances Henry Schein’s medical business with incontinence, urology, ostomy, enteral nutrition, advanced wound, and diabetes supplies, as well as continuous glucose monitoring devices. Headquartered in Valencia, Calif., Shield Healthcare had 2022 net sales of about $180 million.
“As the U.S. population ages and care increasingly moves into the home, Henry Schein is meeting this trend by enhancing our homecare medical products offering,” Stanley M. Bergman, chairman and CEO of Henry Schein told the press. “We are delighted to expand our presence in delivering medical products directly to patients through Shield Healthcare. Together, we share an unwavering commitment to customer satisfaction.”
In July, the company began a deal to acquire the S.I.N. implant system. A week later, it acquired Regional Health Care Group (RHCG).